numbers described in
. The assembled data is available in the repository 125 (www.github.com/DaneshMoradigaravand/PanPred ).
126
127 Pan-genome determination 128 129 Paired-end reads for the isolates sequenced both here and previously were assembled with 130 Velvet [19] and put through an improvement pipeline [20] . In order to reconstruct the pan-131 genome, we used the output assemblies and annotated these with Prokka [21] . The annotated 132 assemblies produced by Prokka were then used as input for Roary [22] to build the pan-genomes 133 with the identity cut-off of 95%. Roary produced a matrix for the presence and absence of 134 accessory genes. The variant sites (SNPs) in the core genome alignment were extracted with an 135 in-house snp_sites tool (www.github.com/sanger-pathogens/snp-sites). To visualize the 136 phylogenetic tree with the associated metadata, we used iTOL [23] . 151 The simulation process begins with a single genome with 3000 core and 6000 accessory genes 152 that undergoes duplication and gene loss/gain in every generation, and continues until a desired 153 number of genomes is reached; we tested population sizes of 130, 260, 650 and 1300. We 154 examined penetrances, defined as the probability of acquisition/loss of the resistance phenotype 235 already contains information about population structure, which reflects the pattern of 236 polymorphisms in the core genome. Indeed, core genome distance and accessory gene difference 237 matrices are not independent (p < 0.01, Mantel test), which is likely explained by accessory genes 238 acquired by clade ancestors, followed by limited turnover. 239 240 Next, we asked which individual features are most frequently utilized. We measured feature 241 importance as the number of times it was used for gradient boosted decision trees, the best 242 performing method, across 50 random fitting replicates on fixed training date ( Figure S4 ). Overall, 243 only an average 3% of input features (653 of 17198) were used at all in prediction across different 244 drugs. In general, known resistance genes were identified as the most important, and were most 245 frequently used features for predicting resistance to beta-lactams and aminoglycosides, e.g. Table S2 ). For example, the known beta-lactamase bla-CTX-M gene ranked first in 248 all models for predicting resistance to beta-lactam ceftazidime, which followed by some genes 249 with unknown function and ampC ( Figure S4A ). Perhaps surprisingly, we found that while the 250 year of isolation was a dispensable feature for nearly all drugs, it was deemed important for 251 ampicillin resistance prediction ( Figure S4B ). This was explained by the temporal distribution of 252 the data, where all the strains collected in 2015 were resistant. These findings demonstrate that 253 although known resistance genes were most predictive, other features, i.e. population structure 254 and year of isolation, may be reproducibly used for prediction as well ( Figure S4B ). Nevertheless, 255 it is clear that the inclusion of some features, such as collection year, reflects bias in the training 256 data rather than biological importance. The current clinical standards employ rule-based models to predict resistance from a small 296 number of known determinants. We used srst2 [29] to identify known resistance genes for 297 cephalosporins, penicillins, aminoglycosides and trimethoprim (Table 2) , and used this 298 information to better understand prediction errors. The best model's false positive resistance 299 calls for different antibiotics contained 2 or 33 isolates that carried known resistance genes (beta-300 lactams, aminoglycoside modifying enzymes and dfr genes), but were annotated as susceptible.
301 Manual inspection confirmed that all of these genes were fully covered by sequence data, and 302 almost identical to the known resistance genes. Moreover, for different antibiotics, one to nine 303 false negative resistance calls (36 total) did not contain a known causal determinant. Similarly, 304 two to nine resistant strains (51 total) were correctly marked as resistant by our model, but 305 contained no known resistance gene (Table 2) . These discrepancies may be explained by either 306 resistance testing error, genomic sequence quality, or unknown mechanisms for resistance. As 307 neither approach was perfect, predictive models in combination with rule-based methods may 308 help identify cases that necessitate further analysis or repeating the susceptibility tests, 309 ultimately leading to improved diagnostics and novel mechanisms. 
328
329 The phenotype data was binary -each isolate was deemed either resistant or not to a compound.
330 It is clear that this is an oversimplification of reality, as substantial variation hides within both 331 categories. As the resistance phenotype is directly exposed to selection, it will influence how 332 quickly it spreads within and between patients, as well as in bacterial populations at large. To 333 predict treatment outcomes, correctly design interventions and allocate societal resources, it will 334 therefore be important to be able to accurately predict resistance quantitatively as well. This 335 requires non-binary resistance data, acquired at high accuracy and throughput. 
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